A detailed history of Phoenix Holdings Ltd. transactions in Gamida Cell Ltd. stock. As of the latest transaction made, Phoenix Holdings Ltd. holds 29,203 shares of GMDA stock, worth $876. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,203
Previous 29,203 -0.0%
Holding current value
$876
Previous $11,000 90.91%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 27, 2021

BUY
$3.85 - $6.44 $112,431 - $188,067
29,203 New
29,203 $114,000
Q2 2021

Aug 10, 2021

SELL
$5.85 - $8.33 $170,837 - $243,260
-29,203 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$7.8 - $12.43 $117,000 - $186,450
-15,000 Reduced 33.93%
29,203 $236,000
Q4 2020

Feb 11, 2021

SELL
$4.07 - $11.0 $61,050 - $165,000
-15,000 Reduced 25.34%
44,203 $370,000
Q2 2020

Aug 10, 2020

BUY
$2.79 - $6.5 $83,700 - $195,000
30,000 Added 102.73%
59,203 $254,000
Q3 2019

Nov 18, 2019

BUY
$3.0 - $5.09 $87,609 - $148,643
29,203 New
29,203 $121,000

Others Institutions Holding GMDA

About Gamida Cell Ltd.


  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Phoenix Holdings Ltd. Portfolio

Follow Phoenix Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.